
Corcept Therapeutics
- Active openings
- 10+
- US-based roles
- 10+
- Remote-friendly
- 0
- Last updated
- 2026-11-14
What Corcept Therapeutics is hiring for
Open positions
10+ active
Contracts ManagerRedwood City, CANov 14
Senior Manager, Oncology Marketing OperationsUSNov 10
Senior Manager, Oncology Marketing OperationsRedwood City, CANov 10
Associate Director, Talent Acquisition (R&D)Redwood City, CANov 5
Director, Health Economics and Outcomes Research (HEOR) USNov 4
About Corcept Therapeutics
Claim to unlockMission, culture, and benefits - visible once this page is claimed and verified.
Updates
From Hazard Ratio to Clinical Impact: Number Needed to Treat in Platinum-Resistant Ovarian Cancer
2-Year Overall Survival Results From DAZALS: A Phase 2, Randomized Controlled Trial of Dazucorilant, a Selective Glucocorticoid Receptor Modulator, in Amyotrophic Lateral Sclerosis
Budget Impact of Relacorilant Plus Nab-Paclitaxel in Patients With Platinum-Resistant Ovarian Cancer: A US Payer Perspective
Infusion Chair Time and Clinic Visits as Drivers of Healthcare Resource Utilization in Platinum-Resistant Ovarian Cancer
Pooled Safety Analysis of Relacorilant Plus Nab-paclitaxel in Patients With Platinum-resistant Ovarian Cancer Enrolled to ROSELLA and Study 552
Meta-analysis of Relacorilant Plus Nab-paclitaxel Efficacy in Patients With Platinum-resistant Ovarian Cancer (PROC) Enrolled to ROSELLA and Study 552